185.80p-0.40 (-0.21%)04 Mar 2021, 08:32
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Convatec Group PLC Fundamentals

Company NameConvatec Group PLCLast Updated2021-03-04
IndustryMedical Instruments & SuppliesSectorHealthcare
Shares in Issue2.004 bnMarket Cap£3.72 bn
PE Ratio175.44Dividend per Share$0.06
Dividend Yield2.33Dividend Cover0.09
EPS$0.00EPS Growth (%)-0.56
PEG1.06DPS Growth (%)-0.0477
Debt Ratio0.4411Debt Equity Ratio0.9971
Asset Equity Ratio2.3461Cash Equity Ratio0.2959
Quick Ratio1.9443Current Ratio2.69
Price To Book Value3.4153ROCE0

Convatec Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Convatec Group PLC Company Financials

Tangible Assets$337.50 m$330.70 m
Intangible Assets$2.17 bn$2.38 bn
Total Fixed Assets$2.64 bn$2.76 bn
Stocks$281.80 m$303.30 m
Debtors$265.10 m$253.70 m
Cash & Equivalents$385.80 m$315.60 m
Other Assets00
Total Assets$3.61 bn$3.66 bn
Creditors within 1 year$397.30 m$330.90 m
Creditors after 1 year$1.65 bn$1.71 bn
Other Liabilities00
Total Liabilities$2.05 bn$2.04 bn
Net assets$1.56 bn$1.62 bn
Called up share capital$242.90 m$240.70 m
Share Premium$70.70 m$39.80 m
Profit / Loss$18.90 m$201.20 m
Other Equity$1.56 bn$1.62 bn
Preference & Minorities00
Total Capital Employed$1.56 bn$1.62 bn
Debt Ratio$0.49$0.49
Assets / Equity2.34612.3461
Cash / Equity0.29590.2959
Cash Flow20192018
Cash from operating activities$401.80 m$352.00 m
Cashflow before financing$149.30 m$122.60 m
Increase in Cash$76.50 m$41.70 m
Turnover$1.83 bn$1.83 bn
Cost of sales$871.60 m$858.30 m
Gross Profit$955.60 m$973.80 m
Operating Profit$96.90 m$267.70 m
Pre-Tax profit$18.90 m$201.20 m

Convatec Group PLC Company Background

ActivitiesOriginally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy are the largest divisions, accounting for 33% and 30% of total revenue, respectively. Continence care contributes 21% of revenue and infusion sets 15%.
Latest Interim Date6 Aug 2020
Latest Fiscal Year End Date5 Mar 2021

Convatec Group PLC Directors

2020-08-28Heather L. MasonDirector
2019-06-28Mr. Jesper OvesenDirector
2019-05-09Sir Christopher Charles GentChairman
2020-10-19Mr. Rick D. AndersonDirector
2018-02-27Nigel ClerkinExecutive Director,Chief Financial Officer
2020-03-20Professor Sten Scheibye, PhDDirector
2019-03-31Steven John HollidayDeputy Chairman
2020-03-11Dr. John David Gibson McAdamChairman
2020-03-13Mr. Brian Michael MayDirector
2020-03-13Ms. Margaret Ewing Senior Independent Director
2020-11-30Karim BitarChief Executive Officer
2020-08-31Dr. Rosalind Catherine Rivaz Director
2020-01-10Dr. Regina M. Benjamin, M.B.A.,M.D.Director
2019-02-27Mr. Paul MoraviecChief Executive Officer
2018-07-03Mr. Kasim KutayDirector
2020-05-05Frank SchulkesChief Financial Officer

Convatec Group PLC Contact Details

Company NameConvaTec Group PLC
Address23 Forbury Road, 3 Forbury Place, Reading, RG1 3JH
Telephone+44 1189528100

Convatec Group PLC Advisors

Remuneration ConsultantKepler Associates
Phone+44 2079307730
Fax+44 2079307733
StockbrokerUBS Limited
Phone+44 2075678000
StockbrokerGoldman Sachs International
Phone+44 2077741000
Financial AdviserEvercore Partners
Phone+44 2076536000
Fax+44 2076536001
Financial PR AdviserFinsbury
Phone+44 2072513801
Fax+44 2073744133
AuditorDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101
SolicitorFreshfields Bruckhaus Deringer
Phone+44 2079364000
Fax+44 2078327001